Posted 8th September 2023 by Ellie Egginton
Enabled by clonal-level microbiome profiling engraftment analysis, metabolomics and multi-omics analysis
The Microbiome & Probiotics R&D and Business Collaboration Forum recently hosted Marianne Koliana, VP of Business Development at Clinical Microbiomics. In the presentation she delved into crucial aspects of clinical trials, including regulatory compliance, engraftment analysis, and the pivotal role of multi-omics approaches, offering a comprehensive understanding of the evolving field.
Posted 10th January 2022 by Nicholas Noakes
It was clear that microbiome companies have been advancing their programs as rapidly as ever, despite the changes brought about by the global pandemic. Service providers—including drug manufacturing organizations—have been busy during the past year, as they continue actively helping diagnostics and therapeutics companies find solutions to advance their products.
Posted 7th September 2021 by Nicholas Noakes
There has been a rapid acceleration of skin microbiome research. Today about 5% of all microbiome clinical studies and 16% of all probiotic products online are dermatology related. Meanwhile, skin probiotics are growing eight times faster than any other probiotic supplement. In clinical cosmetic studies, the microbiome is the fourth largest category.
Posted 22nd July 2021 by Nicholas Noakes
Speaking at the recent Microbiome R&D and Business Collaboration Forum, Anthony Hannan explored research using mouse models for brain disorders, particularly in Huntington’s disease (HD), schizophrenia, depression, and anxiety disorders. He also examined the role of gene-environment interactions involving mental activity, physical activity, stressors, and diet.
Posted 9th February 2021 by Nicholas Noakes
Speaking at the 7th Microbiome & Probiotics Business Collaboration Forum, Liisa Lehtoranta explored the future possible directions for vaginal microbiome research.
Posted 22nd July 2020 by Joshua Sewell
This article is republished with kind permission from BioVox.
A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University.
Posted 29th April 2020 by Liv Sewell
You may have heard; humans are superorganisms. The human large intestine harbors tens of trillions of microbes, which equates to roughly 2 kg of cells. For reference, that’s how much your brain weighs! Within the gut microbiome, it is estimated that there are over 1,000 different species of bacteria.
Posted 22nd April 2020 by Joshua Sewell
Each woman has a unique vaginal microbiota composition, which is dynamic and affected by diet, lifestyle, hormones, genetics, and age. In the past decade, exploration of the human microbiota has focused increasingly on vaginal microbiota composition and diversity and its impact on health, reproduction, and disease.